Acetaminophen by is a Otc medication manufactured, distributed, or labeled by CVS Pharmacy, Inc., Aurohealth LLC, Aurobindo Pharma Limited. Drug facts, warnings, and ingredients follow.
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
Allergy alert: acetaminophen may cause severe skin reactions. Symptoms may include:
If a skin reaction occurs, stop use and seek medical help right away.
Ask a doctor before use if you have liver disease.
Ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin
colloidal silicon dioxide, hydroxyethyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch (maize), sodium starch glycolate, titanium dioxide, triacetin
Questions or comments?
call 1-855-274-4122
Distributed by: CVS Pharmacy, Inc.
One CVS Drive, Woonsocket, Rl 02895
©2023 CVS/pharmacy
CVS.com® 1-800-SHOP CVS
Made in India
Code: TS/DRUGS/22/2009
♥CVS
Health®
Compare to the active ingredient
in Tylenol® 8HR Arthritis Pain*
Tablets
NDC: 69842-037-35
8HR Arthritis
Pain Relief
ACETAMINOPHEN
EXTENDED-RELEASE TABLETS,
USP 650 mg
Pain Reliever/Fever Reducer
For the temporary relief of
minor arthritis pain
Actual
Size
TO OPEN:
1. PUSH DOWN
2. TURN CAP
225 EXTENDED-
RELEASE TABLETS
DO NOT USE WITH OTHER MEDICINES
CONTAINING ACETAMINOPHEN
ACETAMINOPHEN
acetaminophen tablet, extended release |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
Labeler - CVS Pharmacy, Inc. (062312574) |
Registrant - Aurohealth LLC (078728447) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Aurobindo Pharma Limited | 650381903 | ANALYSIS(69842-037) , MANUFACTURE(69842-037) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ACETAMINOPHEN 85615223 not registered Dead/Abandoned |
General Merchandise importers and Expoters 2012-05-03 |